Clinical Trials Directory

Trials / Completed

CompletedNCT05494242

Single Superior ILM/ERM Flap for the FTMH.

Single Superior Internal Limiting Membrane/Epiretinal Membrane Flap for the Full Thickness Macular Hole

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
5 (actual)
Sponsor
Omer Othman Abdullah · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

In this study, the investigators will make the only upper flap either from the internal limiting membrane or from the epiretinal membrane to cover the full thickness macular hole.

Detailed description

After the investigators completed the clinical trial NCT05269563, which was a double flap technique; that consists of two flaps from the internal limiting membrane and the epiretinal membrane. The inferior flap was implanted inside the hole, but the upper flap was utilized to cover the hole. The results were encouraging. Therefore, in this study, the investigators will make the only upper flap to cover the full thickness macular hole, to compare both visual and anatomical outcomes with the double flapped technique (NCT05269563) results. Therefore the double flap will be our control.

Conditions

Interventions

TypeNameDescription
OTHERSurgical interventionPars-plana vitrectomy.

Timeline

Start date
2022-09-01
Primary completion
2023-03-21
Completion
2023-03-21
First posted
2022-08-09
Last updated
2023-03-24

Locations

1 site across 1 country: Iraq

Source: ClinicalTrials.gov record NCT05494242. Inclusion in this directory is not an endorsement.